German drugmaker Bayer and Finland's Orion said on Wednesday a study showed a prostate cancer drug they are jointly developing can delay the spread of the disease to other parts of the body, boosting Orion's shares.
from Reuters: Health https://ift.tt/2SftsT9
via IFTTT
0 comments: